Sarepta Therapeutics (SRPT) FCF Margin (2012 - 2026)
Sarepta Therapeutics' quarterly FCF Margin came in at 51.15% in Q1 2026, up 41916.0% year-on-year from N/an in Q1 2025, and down 277.55% quarter-over-quarter from 28.81% in Q4 2025.
Sarepta Therapeutics has reported FCF Margin for 13 years, with the latest figure at 51.15% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin rose 41916.0% year-over-year to 51.15%; the trailing twelve-month figure through Mar 2026 stood at 6.2% (up 4907.0% YoY), and the FY2025 full-year result was 13.99%, up 403.0% from the prior year.
- FCF Margin for Q1 2026 stood at 51.15%, down from 28.81% in the prior quarter.
- The five-year high for FCF Margin was 37.56% in Q2 2025, with the low at 629.86% in Q2 2023.
- Average FCF Margin over 5 years is 114.17%, with a median of 35.93% recorded in 2022.
- Year-over-year, FCF Margin slumped 59392 bps in 2023 and surged 62594 bps in 2024.
- Tracing SRPT's FCF Margin over 5 years: stood at 59.32% in 2022, then jumped by 73 bps to 15.9% in 2023, then jumped by 152 bps to 8.2% in 2024, then soared by 252 bps to 28.81% in 2025, then slumped by 278 bps to 51.15% in 2026.
- The last three FCF Margin figures came in at 51.15% (Q1 2026), 28.81% (Q4 2025), and 9.39% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.17% |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | -51.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.15% |
| Dec 31, 2025 | 28.81% |
| Sep 30, 2025 | -9.39% |
| Jun 30, 2025 | 37.56% |
| Mar 31, 2025 | -470.32% |
| Dec 31, 2024 | 8.20% |
| Sep 30, 2024 | -23.11% |
| Jun 30, 2024 | -3.92% |
| Mar 31, 2024 | -66.40% |
| Dec 31, 2023 | -15.90% |
| Sep 30, 2023 | -43.51% |
| Jun 30, 2023 | -629.86% |
| Mar 31, 2023 | -86.34% |
| Dec 31, 2022 | -59.32% |
| Sep 30, 2022 | -35.23% |
| Jun 30, 2022 | -35.93% |
| Mar 31, 2022 | -485.01% |
| Dec 31, 2021 | -28.16% |
| Sep 30, 2021 | -70.52% |
| Jun 30, 2021 | -81.11% |
| Mar 31, 2021 | -137.15% |
| Dec 31, 2020 | -903.11% |
| Sep 30, 2020 | -1,171.32% |
| Jun 30, 2020 | -487.23% |
| Mar 31, 2020 | 4,677.68% |
| Dec 31, 2019 | -180.85% |
| Sep 30, 2019 | -77.60% |
| Jun 30, 2019 | -101.08% |
| Mar 31, 2019 | -186.75% |
| Dec 31, 2018 | -168.95% |
| Sep 30, 2018 | -169.98% |
| Jun 30, 2018 | -171.29% |
| Mar 31, 2018 | -74.04% |
| Dec 31, 2017 | -61.03% |
| Sep 30, 2017 | -127.67% |
| Jun 30, 2017 | -251.40% |
| Mar 31, 2017 | -381.55% |
| Dec 31, 2014 | -105,881.48% |
| Sep 30, 2014 | -4,512.28% |
| Jun 30, 2014 | -1,704.18% |
| Mar 31, 2014 | -551.76% |
| Dec 31, 2013 | -701.83% |
| Sep 30, 2013 | -508.76% |
| Jun 30, 2013 | -421.15% |
| Mar 31, 2013 | -335.32% |
| Dec 31, 2012 | -97.57% |
| Sep 30, 2012 | -102.59% |
| Jun 30, 2012 | -51.90% |
| Mar 31, 2012 | -80.79% |